Drug Research

Veracyte, Inc. announced a research collaboration through which Loxo Oncology will access Veracyte’s new Afirma Xpression Atlas platform to advance its development of highly selective…
Read More...

Inovio Pharmaceuticals and CEPI – the Coalition for Epidemic Preparedness Innovations – announced a partnership under which Inovio will develop vaccine candidates against Lassa fever…
Read More...

Pfizer has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX's network of healthcare organizations to support…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor DISPERZ (everolimus tablets for oral suspension), for the adjunctive treatment of adult and…
Read More...

Charles River Laboratories International, Inc. and PathoQuest announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS) services to the…
Read More...

Ubiquigent Limited announced that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel…
Read More...

Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in oncology, vaccines, and general medicine announced that it has signed a merger agreement with…
Read More...

Proteostasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the Company's triple combination program for the treatment of…
Read More...

Compugen Ltd. announced it entered into an exclusive license agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to enable the development of…
Read More...

Q-State Biosciences announced that the company has entered into a strategic collaboration with Vertex Pharmaceuticals Incorporated to discover drugs using Q-State’s novel Optopatch…
Read More...

Dr. Reddy’s Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine candidate DFN-02 with the U.S. Food and Drug…
Read More...

FORMA Therapeutics and Arpeggio Biosciences announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of…
Read More...

Prothena Corporation announced a global collaboration with Celgene Corporation to develop new therapies for a broad range of neurodegenerative diseases. The multi-year research and…
Read More...

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals announced a collaboration to identify RNAi therapeutics for the chronic liver disease nonalcoholic steatohepatitis (NASH) and…
Read More...

Horizon Discovery Group announces that one of the licensees to its Bioproduction cell line technology has used Horizon’s cell line as part of a successful Investigational New Drug (IND)…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis® (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the…
Read More...

Biocom, the association representing the life science industry of California, concluded its Regenerative Medicine Advocacy Fly-In to Washington, D.C. yesterday, the culmination of…
Read More...

Pfizer and Astellas Pharma announced that a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) has been accepted for filing and granted Priority Review designation by…
Read More...

Kalytera Therapeutics announced that it has begun development of a novel cannabinoid-based compound for the treatment of acute and chronic pain. Patents for this compound have been…
Read More...

Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm committed to the…
Read More...